Una nueva inmunoterapia combinada prolonga la supervivencia de los pacientes con cáncer de riñón avanzado Denise Mann Hola Doctor 25 Apr, 2022 Consumer News in Spanish
New Combo Immunotherapy Prolongs Survival in Patients With Advanced Kidney Cancer Denise Mann Apr 22, 2022 Consumer News
Missed Cancer Screenings During Pandemic Could Raise Death Rate for Years Amy Norton Mar 21, 2022 Consumer News
Los pacientes con cáncer podrĂan tener más probabilidades de un raro trastorno neurolĂłgico Robert Preidt Hola Doctor 04 Mar, 2022 Consumer News in Spanish
Cancer Patients May Be at Higher Odds for Rare Neurological Disorder Robert Preidt Mar 03, 2022 Consumer News
Women at Higher Odds for Side Effects From Some Cancer Treatments Robert Preidt Feb 15, 2022 Consumer News
Belzutifan Active in Renal Cell Carcinoma Associated With VHL Disease Physician’s Briefing Staff Dec 10, 2021 Physician's Briefing
Treatments Compared for Advanced Renal Cell Carcinoma Physician’s Briefing Staff 03 Dec, 2021 Physician's Briefing
Cancer Care Costs U.S. $156 Billion Per Year; Drugs a Major Factor Robert Preidt 13 Oct, 2021 Consumer News
Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma Physician’s Briefing Staff 19 Aug, 2021 Physician's Briefing
For People With Heart Failure, Statins May Lower Cancer Risk Too Robert Preidt Ernie Mundell 24 Jun, 2021 Consumer News
ASCO: Pembrolizumab Ups DFS in High-Risk Resected Clear-Cell RCC Physician’s Briefing Staff 04 Jun, 2021 Physician's Briefing
Occult Brain Mets Detected in Patients With Advanced Renal Cancer Physician’s Briefing Staff 03 May, 2021 Physician's Briefing
Nivolumab Plus Cabozantinib Tops Sunitinib for Renal Cell Carcinoma Physician’s Briefing Staff 03 Mar, 2021 Physician's Briefing
Un medicamento mejora la supervivencia a un raro y letal cáncer de riñón Robert Preidt Hola Doctor 23 Feb, 2021 Consumer News in Spanish
Lenvatinib Plus Pembrolizumab Tops Sunitinib in Advanced RCC Physician’s Briefing Staff 19 Feb, 2021 Physician's Briefing
Cabozantinib Prolongs PFS in Papillary Renal Cell Carcinoma Physician’s Briefing Staff 17 Feb, 2021 Physician's Briefing